Cited by 179MicroRNA in disease regulationCytokine Signaling Pathways and Interactionsinterferon and immune responses

IFN Induces miR-21 through a Signal Transducer and Activator of Transcription 3–Dependent Pathway as a Suppressive Negative Feedback on IFN-Induced Apoptosis

Open access
Yang, Chuan He, Yue, Junming, Fan, Meiyun, Pfeffer, Lawrence M.·2010·Cancer Research

Published version of a preprint

Abstract

The microRNA miR-21 is overexpressed in many human cancers, wherein accumulating evidence indicates that it functions as an oncogene. Here, we report that the cytokine IFN rapidly induces miR-21 expression in human and mouse cells. Signal transducer and activator of transcription 3 (STAT3) was implicated in this pathway based on the lack of IFN effect on miR-21 expression in prostate cancer cells with a deletion in the STAT3 gene. STAT3 ablation abrogated IFN induction of miR-21, confirming the important role of STAT3 in regulating miR-21. Chromatin immunoprecipitation analysis showed that STAT3 directly bound the miR-21 promoter in response to IFN. Experiments in mouse embryo fibroblasts with a genetic deletion of the p65 NF-κB subunit showed that IFN-induced miR-21 expression was also dependent on NF-κB. STAT3 silencing blocked both IFN-induced p65 binding to the miR-21 promoter and p65 nuclear translocation. Thus, IFN-induced miR-21 expression is coregulated by STAT3 and NF-κB at the level of the miR-21 promoter. Several cell death regulators were identified as downstream targets of miR-21, including PTEN and Akt. Functional experiments in prostate cancer cells directly showed that miR-21 plays a critical role in suppressing IFN-induced apoptosis. Our results identify miR-21 as a novel IFN target gene that functions as a key feedback regulator of IFN-induced apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-2579

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Modulating miR-21 expression in in vivo and in vitro studies shows clear and important phenotype changes.

    “Modulating its expression in in vivo and in vitro studies show clear and important phenotype changes.”

    From miR-21: a non‐specific biomarker of all maladies (2021) · cites this paper as [16]

    The Results section, “miR-21 expression suppresses IFN-induced apoptosis” (page unavailable), reports clear changes in apoptosis after miR-21 overexpression or knockdown in cultured cancer cells. Our copy does not report an in vivo experiment showing a phenotype change, so it supports only the in vitro part of the claim. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [5]Yang CH Shi W Basu L Direct association of STAT3 with the IFNAR1 signal transducing chain of the type I IFN receptor J Biol Chem 1996 271 8057 61 8626489

Cited by

Sorted by citations

Authors
Yang, C. H., Yue, J., Fan, M., & Pfeffer, L. M.
Affiliations
University of Tennessee Health Science Center (US)
Corresponding author
Pfeffer, Lawrence M.
Venue
Cancer Research
Published
2010-10-13
Volume
70
Issue
20
Pages
8108-8116
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2072751712
Cited by
179
References
31
Citations by year
2026: 2 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 8 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 17 · 2015: 24 · 2014: 16 · 2013: 15 · 2012: 20
FWCI
5.04
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Biogen
  • IC Design Education Center
  • U.S. Public Health Service (RHL095957)
  • National Heart, Lung, and Blood Institute (R21HL095957)
  • National Cancer Institute (R01CA133322, CA133322, R01CA140346)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
miR-21, interferon, STAT3, NF-κB, NF-κB p65, negative feedback regulation, apoptosis, PTEN, Akt, prostate cancer, microRNA regulation, oncogenes
MeSH terms
Animals, Feedback, Fibroblasts, Humans, Interferons, Male, Prostatic Neoplasms, Signal Transduction, Apoptosis, DNA Primers, DNA, Complementary, Mice, Knockout, Gene Silencing, MicroRNAs, STAT3 Transcription Factor, Mice, Transcription Factor RelA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review